← Back to Search

Behavioural Intervention

Telehealth Group Counseling for Cardiovascular Disease

N/A
Recruiting
Led By Diala Steitieh, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female patients aged 18 and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before and immediately after each counseling session, up to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to use online group counseling sessions to help improve the health of female patients with heart disease.

Who is the study for?
This trial is for women with various heart conditions such as heart attack, angina, and coronary artery disease. Participants should have atherosclerotic cardiovascular disease (ASCVD) and be interested in joining group counseling sessions via telehealth to improve their health management.
What is being tested?
The study is testing the effectiveness of group counseling sessions conducted through telehealth as a way to help female patients better manage their heart conditions and adhere to treatment plans.
What are the potential side effects?
Since this trial involves non-medical intervention through telehealth counseling, there are no direct medical side effects associated with drugs or procedures. However, participants may experience emotional or psychological responses to discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 18 or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before and immediately after each counseling session, up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before and immediately after each counseling session, up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in medication compliance as assessed by Likert scale.
Change in overall patient satisfaction as assessed by Likert scale.
Change in patient's accessibility to care as assessed by Likert scale.
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Telehealth CounselingExperimental Treatment1 Intervention
Telehealth sessions

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,154,696 Total Patients Enrolled
Diala Steitieh, MDPrincipal InvestigatorWeill Medical College of Cornell University
~22 spots leftby Apr 2025